Atypical antipsychotics will be used more for treating depression

May 2009

Atypical antipsychotics will be used more for treating depression.

Both Abilify (aripiprazole) and Symbyax (olanzapine/fluoxetine) are already approved for resistant depression...and Seroquel (quetiapine) will likely get a similar indication.

More than half of patients with depression still have symptoms despite an adequate trial of an antidepressant.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

you'll have more patients asking for help to afford their medications
Cardiology whether it's appropriate to use aspirin plus clopidogrel (Plavix) for patients with atrial fibrillation
Cardiology whether statins can prevent VENOUS thromboembolism
Gastroenterology what to use for irritable bowel syndrome (IBS)
Men's Health Rapaflo (silodosin), a new selective alpha-blocker for benign prostatic hyperplasia (BPH)
Pharmacy Technicians new state requirements for pharmacy technicians
generic substitution of long-acting calcium channel blockers (Cardizem CD, Tiazac, etc)
Vitamins & Minerals bigger push for people to get more vitamin D
Migraine which triptan to use for migraines
Psychiatry Atypical antipsychotics will be used more for treating depression
Neurology & Pain Ryzolt (RYE-zolt), a new once-daily tramadol
Neurology & Pain concerns about opioid shortages
People will ask about H1N1 "swine" flu

Atypical antipsychotics will be used more for treating depression

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents